Nacre Capital

What is Nacre Capital?

Nacre Capital is a venture capital firm specializing in the early-stage and seed investment of startups, leveraging a venture-building model. They focus on creating, building, and growing disruptive start-ups that employ deep technologies to significantly impact lives across various segments. The firm identifies fundamental needs and explores groundbreaking solutions to address them, prioritizing scalability and market fit.

Nacre Capital adopts a hands-on approach to company creation, recruiting top talent, and providing comprehensive support, including financial, business development, and legal assistance.

Their commitment to staying actively involved throughout the growth phase ensures that their ventures can scale globally. Nacre Capital's inhouse portfolio includes companies that solve complex problems using real breakthrough innovations in Health, Bio-Technology, Agriculture, Aquaculture, Security, and Culture.

Some of their portfolio companies are FDNA, a digital health and AI firm; Fairtility, innovating in AI-based embryo selection; CureSign, with a cancer treatment monitoring solution; Seed-X, offering AI-based seed analysis solution; Aquaticode, enabling precision farming in aquaculture, and more.

The firm also boasts a unique edge from its focus on deep technology and strong R&D, resulting in over 200 academic papers, 500+ academic research collaborations, and 140+ granted patents.

The partners at Nacre Capital bring diverse expertise and decades of experience, including Howard Morgan, with a history of investments in companies like Uber and LinkedIn, and Moti Shniberg, a serial entrepreneur with successful ventures such as Face.com (acquired by Facebook). Nacre Capital operates with a global presence and a team that has backed businesses impacting billions of customers with successful exits through IPOs or acquisitions by market leaders.